Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Oncolytic Viruses / Non-viral Gene Therapy Delivery
November 30 - December 1, 2022
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET
Menu

Victor Cervera-Carrascón
Vice President of Business Development at TILT Biotherapeutics, Finland
Speaker

Agenda Sessions

  • Emerging Results with a Cytokine Armed Oncolytic Adenovirus Designed to Enable T-cell Responses

    , 11:20am
    View Session

At this event

Prev
Next
Mohammad Ali Amini
President & CEO
QurCan Therapeutics Inc., Canada

See Victor at Oncolytic Viruses / Non-viral Gene Therapy Delivery